Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Merck & Co., Inc.

Cathie Wood-led ARK Invest made several notable trades on Friday, September 4, with Robinhood Markets ($HOOD), an online brokerage and financial-se...

Cathie Wood Buys $3.6M of HOOD, Sells $2.9M of 2 High-Growth Stocks – September 5

Jefferies analyst James Vane maintained a Hold rating on Merck KGaA today and set a price target of €144.00. According to TipRanks, Vane is an anal...

Jefferies Reaffirms Their Hold Rating on Merck KGaA (0O14)

RedHill Biopharma ($RDHL) divested its Talicia business to Apotex Health Corp. in an $18 million upfront plus potential milestones deal as part of ...

RedHill Sells its Talicia® H. pylori Drug Business to Apotex in $18M Deal to Fuel Growth

TipRanks’ ETF AI Analyst has an Outperform rating on the Invesco NASDAQ 100 ETF ($QQQM), Vanguard High Dividend Yield Index ETF ($VYM), and iShares...

3 ETFs to Buy with 10%+ Total Returns, According to the AI Analyst

In a report released on August 25, Trung Huynh from RBC Capital maintained a Hold rating on Merck & Company, with a price target of $150.00. The co...

RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)

Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Vivmark Residential (VMRK) and Host Hotels & Reso...

Analysts Have Conflicting Sentiments on These Real Estate Companies: Vivmark Residential (VMRK) and Host Hotels & Resorts (HST)

Merck & Company ( ($MRK) ) has risen by 12.19%. Read on to learn why. Merck & Company shares climbed 12.19% over the past week as investors digeste...

Merck & Company Soars on Breakthrough Cancer Vaccine Hopes

Analysts are intrested in these 5 stocks: ( ($MRNA) ), ( ($ADI) ), ( ($MRK) ), ( ($EPR) ) and ( ($TJX) ). Here is a breakdown of their recent


Moderna, ADI, Merck, EPR, TJX: Trending With Analysts

Shares in Moderna ($MRNA) climbed by 13% to $151 per share on Friday afternoon. This came even after JPMorgan’s five-star analyst Jessica Fye repea...

Moderna Stock (MRNA) Jumps 13% Despite JPMorgan’s Sell Rating

Merck & Co. ($MRK), a U.S. pharmaceutical firm, got a major boost on Thursday, August 20, after investment banks Morgan Stanley ($MS), UBS ($UBS) a...

Merck Stock (MRK) Is a Strong Buy Now as 3 Top Wall Street Analysts Hike Price Targets

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Marker Therapeutics (MRKR) and CSPC Pharmaceutical G...

Analysts Offer Insights on Healthcare Companies: Marker Therapeutics (MRKR) and CSPC Pharmaceutical Group (OtherCHJTF)

According to a report in the Wall Street Journal, Costco ($COST) is about to launch its own Medicare Advantage plan in two states as part of a limi...

Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.

Tempus AI ($TEM) surged nearly 24% on Wednesday after a major Phase 3 cancer vaccine update from Merck ($MRK) and Moderna ($MRNA). The news instant...

Tempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Merck & Company (MRK), Moderna (MRNA) and Akari Th...

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Moderna (MRNA) and Akari Therapeutics (AKTX)

Pfizer stock was up 3.74% thanks to a clinical trial update from Merck and Moderna that showed the potential of an MRNA vaccine as a cancer treatme...

Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amylyx Pharmaceuticals Inc (AMLX), Moderna (MRNA) ...

Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Moderna (MRNA) and Merck & Company (MRK)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ACADIA Pharmaceuticals (ACAD), Insmed (INSM) and Mer...

Analysts Are Bullish on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD), Insmed (INSM)

In a report released today, Brendan Lynch from Barclays maintained a Buy rating on Newmark Group, with a price target of $20.00. According to TipRa...

Barclays Sticks to Their Buy Rating for Newmark Group (NMRK)

Insiders have been trading these 5 stocks: (($ET)), (($MRK)), (($LMT)), (($CRWV)) and (($TWLO)). Here is a breakdown of their recent trades and the...

Energy Transfer, Merck, Lockheed, CoreWeave, Twilio Insider Shock

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Hold rating on Merck KGaA, with a price target of €141.00. According t...

Deutsche Bank  Sticks to Its Hold Rating for Merck KGaA (0O14)

Insiders have been trading these 5 stocks: (($COIN)), (($GM)), (($DAL)), (($MRK)) and (($APLD)). Here is a breakdown of their recent trades and the...

Coinbase, GM, Delta, Merck, Applied Digital: Insider Shock

In a report released yesterday, Peter Spengler from DZ BANK AG maintained a Buy rating on Merck KGaA. The company’s shares closed last Thursday at ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MRK	$150.33	-1.32%	4.40M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MRK	$150.33	-1.3%	4.40M
3
4
5
6

MRK

Get Merck & Co., Inc. Data in Excel

Get Merck & Co., Inc. Data in Excel